IonQ advances to final stage of DARPA Quantum Benchmarking Initiative
IonQ announced it has moved to Stage C, the final phase of DARPA’s Quantum Benchmarking Initiative. The agreement with DARPA could be worth up to $300 million and will fund testing of IonQ’s Superion systems through 2029. The news lifted the stock in after‑hours and pre‑market trading, with shares rising about 1‑2% to roughly $42. The company highlighted its 371% revenue growth over the past twelve months and a market value of $15.5 billion.
Why it matters
The company says the DARPA award provides government validation and a potential multi‑year funding stream, which could accelerate commercial deployments of its quantum hardware (the company expects). Analysts note the validation may improve the stock’s upside potential, with B. Riley maintaining a $100 price target and BofA initiating coverage with a $60 target (analyst commentary).
Key facts
- 1IonQ reached Stage C of DARPA’s Quantum Benchmarking Initiative, the final stage of the program. tipranks.com
- 2The DARPA agreement has a potential value of up to $300 million, contingent on future appropriations. tipranks.com
- 3The agreement will support testing of IonQ’s Superion systems through 2029. benzinga.com
- 4IonQ’s stock rose 1.17% in after‑hours trading to $41.83. tipranks.com
- 5IonQ’s stock was up 1.67% in pre‑market trading to $42.03. benzinga.com
- 6IonQ’s market capitalization is $15.5 billion. investing.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.